Armour Energy Ltd (AJQDA) News

Form 8-K - Current report

Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus

SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) --  Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a...

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering

SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a...

Form 8-K - Current report

Form 424B4 - Prospectus [Rule 424(b)(4)]

Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a...

Form EFFECT - Notice of Effectiveness

Form 8-K - Current report

Form 8-K - Current report